AMINO ACID PLASMA - QUALITATIVE SCREEN

Amino Acid Plasma - Qualitative Screen is a specialized blood test used to examine the overall pattern of amino acids present in plasma. Amino acids are essential molecules required for protein synthesis, growth, tissue repair, energy production, neurotransmitter formation, and several important metabolic processes within the body.

This qualitative screening test helps identify unusual amino acid patterns that may be associated with inherited disorders of amino acid metabolism, urea-cycle disorders, organic acid disorders, nutritional abnormalities, liver disease, kidney dysfunction, or other metabolic conditions. The test indicates whether significant amino acid abnormalities are present but does not necessarily provide an exact concentration for every amino acid. Abnormal findings may require confirmation through quantitative plasma amino acid analysis, urine organic acid testing, genetic testing, enzyme studies, or other specialized investigations.

Benefits of the Test

• Screens for abnormal plasma amino acid patterns.
• Supports evaluation of inherited metabolic disorders.
• Helps investigate abnormal newborn screening results.
• Assists in evaluating unexplained neurological or developmental symptoms.
• Supports investigation of recurrent metabolic illness.
• Helps guide further quantitative and genetic testing.
• May assist in monitoring known amino acid metabolism disorders.
• Provides reliable laboratory-based metabolic screening.

Why Doctors Recommend This Test

Doctors may recommend this test for newborns, children, or adults with unexplained developmental delay, poor growth, feeding difficulty, recurrent vomiting, seizures, altered consciousness, abnormal muscle tone, unusual body or urine odor, metabolic acidosis, high ammonia, liver dysfunction, or a family history of inherited metabolic disease. It may also be advised after an abnormal newborn screening result or when a patient is suspected of having an amino acid metabolism disorder.

Preparation Before Test

• A plasma blood sample is required for testing.
• Fasting for approximately four hours may be required depending on laboratory protocol.
• For infants, collection may be advised immediately before the next feeding.
• Urgent testing in a symptomatic newborn or patient should not be delayed solely to obtain a fasting specimen.
• Inform the doctor about medicines, supplements, medical formulas, diet, and total parenteral nutrition.
• Do not change the prescribed diet or stop medicines unless instructed by the treating specialist.
• Provide the patient's age, symptoms, clinical condition, and relevant family history.
• The sample must be collected in the laboratory-recommended tube and processed promptly.
• Plasma should be separated, stored, and transported according to laboratory instructions.

Normal Reporting Time

Most Amino Acid Plasma - Qualitative Screen reports at Focus Diagnostics are initiated within 2–3 hours of sample receipt for processing and metabolic testing workflow preparation. Final amino acid screening, pattern evaluation, quality review, validation, and reporting are generally completed within several working days, depending on laboratory protocols, sample condition, and quality-assurance requirements.

Who Should Take This Test?

This test may be recommended for:

• Newborns with an abnormal metabolic screening result.
• Infants with poor feeding, vomiting, lethargy, or failure to thrive.
• Children with developmental delay or intellectual disability.
• Patients with seizures, abnormal muscle tone, or altered consciousness.
• Individuals with recurrent metabolic acidosis or elevated ammonia.
• People with unusual body, breath, or urine odor.
• Individuals with a family history of an inherited metabolic disorder.
• Patients requiring preliminary assessment of amino acid metabolism.

Detailed Information

Amino acids are obtained from dietary protein and are also produced or recycled through normal metabolism. The body maintains carefully controlled amino acid levels through digestion, absorption, cellular transport, enzyme activity, liver metabolism, kidney function, and protein breakdown.

Inherited defects affecting an enzyme or transport protein can cause one or more amino acids to become abnormally increased or decreased. Accumulated amino acids or their metabolic by-products may become toxic, while deficiencies can interfere with growth, energy production, brain development, and normal organ function.

Plasma amino acid screening may help identify patterns associated with conditions such as phenylketonuria, Maple Syrup Urine Disease, homocystinuria, tyrosinemia, citrullinemia, argininosuccinic aciduria, ornithine transcarbamylase deficiency, and other disorders of amino acid or urea-cycle metabolism. However, this qualitative screening test alone cannot establish a final diagnosis.

The test evaluates the general plasma amino acid pattern and identifies significant abnormalities detectable by the analytical method. A normal result means that no major qualitative abnormality was detected, but it does not exclude every inherited metabolic disorder. Some conditions may only produce abnormalities during illness, fasting, metabolic stress, or particular stages of life.

Amino acid patterns can also be influenced by recent food intake, age, medicines, supplements, medical formulas, liver disease, kidney failure, nutritional status, infection, burns, muscle disease, and sample-handling conditions. All relevant clinical information should therefore be provided to the laboratory.

For the most reliable interpretation, the plasma sample should be collected and processed according to laboratory requirements. Delayed separation of plasma, inappropriate storage, hemolysis, or prolonged contact with blood cells may alter some amino acid levels and affect the screening pattern.

If the qualitative screen identifies a suspicious pattern, the doctor may recommend quantitative plasma amino acid analysis. Quantitative testing measures the concentration of individual amino acids and allows comparison with age-specific reference intervals.

Additional investigations may include urine amino acid analysis, urine organic acid profiling, blood acylcarnitine analysis, ammonia, lactate, blood glucose, liver-function tests, enzyme studies, molecular genetic testing, or cerebrospinal fluid amino acid analysis. The choice of follow-up testing depends on the abnormal pattern and clinical presentation.

Early identification of inherited metabolic disorders is important because some conditions can be managed through specialized diets, medical formulas, supplements, medicines, or emergency metabolic treatment. Prompt diagnosis may help prevent metabolic crises, neurological injury, developmental complications, and organ damage.

Results should always be interpreted by a pediatrician, neurologist, metabolic specialist, geneticist, or other qualified healthcare professional alongside symptoms, physical findings, age, diet, family history, and additional laboratory investigations.

At Focus Diagnostics, Amino Acid Plasma - Qualitative Screen testing is performed using validated metabolic screening methodologies, specialized sample-processing procedures, and stringent quality-assurance standards to provide accurate, reliable, and clinically meaningful results.